FREENOME PRESENTS A SUBJECT POPULATION ANALYSIS OF A CLINICAL STUDY USING A MULTIOMICS BLOOD TEST FOR THE EARLY DETECTION OF COLORECTAL CANCER

/PRNewswire/ -- Today Freenome, a privately held biotech company, presents a subject population analysis from PREEMPT CRC, a study for the detection of...

Related Keywords

California ,United States ,Portland ,Oregon ,South San Francisco ,American ,Lance Baldo ,Aasma Shaukat ,Langone Health ,Division Of Gastroenterology ,Colorectal Cancer Consortium Conference In Portland ,Colorectal Cancer Consortium Conference ,Drug Administration Office Of Women Health ,Freenome Holdings Inc ,American Cancer Society ,Western Colorectal Cancer Consortium ,Western Colorectal Cancer Consortium Conference ,Health Research United States Food ,Drug Administration Office ,Freenome Holdings ,Nc ,